Here, using small molecule therapeutics, we show that combined inhibition of MYCN transcription by BET inhibitors (JQ1/OTX) and mTOR signaling by TEM, synergistically inhibited NB cell growth and survival. Here, MYCN is linked to neuroblastoma.